Decoding spliceosome inhibition: Isobaric tag-based proteomic profiling of pladienolide B treated human cell lines.

Pladienolide B (Pla-B) is a potent splicing modulator that has shown promise in cancer treatment, but its cellular effects remain incompletely understood. We investigated the dose-associated effect of Pla-B on human cell lines using isobaric tag-based quantitative proteomics and phosphoproteomics techniques. We quantified over 10,000 proteins and 19,000 phosphorylation events in SH-SY5Y cells, revealing dose-associated changes in protein abundance and phosphorylation status. Low Pla-B concentrations induced significant alterations in nuclear proteins, specifically those involved in transcription and cell division. Higher concentrations led to more extensive proteome remodeling, affecting chromatin-associated proteins and transcription. Phosphoproteome analysis uncovered alterations in the phosphorylation states of proteins including the splicing factor subunit SF3B, suggesting complex regulation of signaling pathways. Our findings reveal the detailed proteomic landscape of Pla-B's effects, offering insights into its role in the global proteome, which may guide future therapeutic applications and rational drug design.

• Publication year

  2025

• Venue

  Journal of Proteomics

• Publication date

  2025-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jprot.2025.105565PMID 41224195PMCID PMC12664570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1

  2023cited by this paper
• Enhancing Proteome Coverage by Using Strong Anion-Exchange in Tandem with Basic-pH Reversed-Phase Chromatography for Sample Multiplexing-Based Proteomics.

  2023cited by this paper
• Comparative Proteomic Analysis of Two Commonly Used Laboratory Yeast Strains: W303 and BY4742

  2023cited by this paper
• Spin column-based peptide fractionation alternatives for streamlined tandem mass tag (SL-TMT) sample processing.

  2023cited by this paper
• Spliceosome inhibitor induces human hematopoietic progenitor cell reprogramming toward stemness

  2022cited by this paper
• GPS 5.0: An Update on the Prediction of Kinase-specific Phosphorylation Sites in Proteins

  2020cited by this paper
• Isobaric Tag‐Based Protein Profiling across Eight Human Cell Lines Using High‐Field Asymmetric Ion Mobility Spectrometry and Real‐Time Database Searching

  2020cited by this paper
• Accurate Quantitative Proteomic Analyses Using Metabolic Labeling and High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS).

  2019cited by this paper
• An optimized workflow for multiplexed phosphorylation analysis of TMT-labeled peptides using high-Field Asymmetric waveform Ion Mobility Spectrometry (FAIMS).

  2019cited by this paper
• Streamlined Tandem Mass Tag (SL-TMT) Protocol: An Efficient Strategy for Quantitative (Phospho)proteome Profiling Using Tandem Mass Tag-Synchronous Precursor Selection-MS3.

  2018cited by this paper
• An Internal Standard for Assessing Phosphopeptide Recovery from Metal Ion/Oxide Enrichment Strategies

  2018cited by this paper
• The PRIDE database and related tools and resources in 2019: improving support for quantification data

  2018cited by this paper
• Modulating splicing with small molecular inhibitors of the spliceosome

  2017cited by this paper
• Multiple testing corrections in quantitative proteomics: A useful but blunt tool

  2016cited by this paper
• Quantitative mass spectrometry-based multiplexing compares the abundance of 5000 S. cerevisiae proteins across 10 carbon sources.

  2016cited by this paper
• RNA mis-splicing in disease

  2015cited by this paper
• Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B

  2015cited by this paper
• PhosphoSitePlus, 2014: mutations, PTMs and recalibrations

  2014cited by this paper
• A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors

  2013cited by this paper
• High antitumor activity of pladienolide B and its derivative in gastric cancer

  2013cited by this paper
• The spliceosome as a target of novel antitumour drugs

  2012cited by this paper
• Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses.

  2012cited by this paper
• Biological validation that SF3b is a target of the antitumor macrolide pladienolide

  2011cited by this paper
• Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• A tissue-specific atlas of mouse protein phosphorylation and expression.

  2010cited by this paper
• Target-Decoy Search Strategy for Mass Spectrometry-Based Proteomics

  2010cited by this paper
• Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/Orbitrap mass spectrometer.

  2009cited by this paper
• Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches

  2009cited by this paper
• The spliceosome: design principles of a dynamic RNP machine.

  2009cited by this paper
• Splicing factor SF3b as a target of the antitumor natural product pladienolide

  2007cited by this paper
• Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

  2007cited by this paper
• A probability-based approach for high-throughput protein phosphorylation analysis and site localization

  2006cited by this paper
• The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site

  2006cited by this paper
• Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. I. Taxonomy, fermentation, isolation and screening.

  2004cited by this paper
• Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

  1973cited by this paper

• No citing papers are available for this paper.